Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “aflibercept”

6 pharma patents match "aflibercept" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 6
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 6 pharmaceutical patents matching "aflibercept" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

6 results for “aflibercept” · 30,257 patents in full index Clear search

  1. US 11667702

    Stable aqueous formulations of aflibercept

    Coherus BioSciences, Inc. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted

  2. US 11535663

    Methods for producing aflibercept in chemically defined media having reduced aflibercept variants

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted

  3. US 11472861

    Methods for producing aflibercept in chemically defined media having reduced aflibercept variants

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted

  4. US 11426446

    Stable aqueous formulations of aflibercept

    Coherus BioSciences, Inc. · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  5. US 11104715

    Methods for producing aflibercept in chemically defined media having reduced aflibercept variants

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted

  6. US 11071780

    Methods and formulations for treating vascular eye diseases using aflibercept and nesvacumab

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.